[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f_xdrTKgLy-7QFtPyTIY_-xOHhE30gQUPkgLom7WNHeo":8,"$fBMRCrGnOe-MgU_tv6-voNOA9l0lhggNL_G4QeDB4bgk":55,"$f2EzhDjIu_oO-IJHzI9NaVmNtsRw5zAAal_BkQy_qvn8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},48752,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"食管鳞癌治疗新选择：卡铂、白蛋白紫杉醇与信迪利单抗联合方案用药全细节","","https://ystcdn.venuertc.com/venue/AI/b06d1a44-3de7-47bc-9a24-be8267500e30.jpg","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">食管鳞癌治疗新选择：卡铂、白蛋白紫杉醇与信迪利单抗联合方案用药全细节\u003C/h2>\n  \n  \u003C!-- 引入说明 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Cdiv class=\"drug-guide-intro-bg\">\n      \u003Cp>卡铂、白蛋白紫杉醇和信迪利单抗，是目前在肿瘤治疗领域越来越常用的一组药物组合。它们各有特点，常被联合使用，提高治疗效果。想安全用好这三种药，每个细节都值得用心。下面就围绕这套方案，我们详细拆解8个必须关注的用药细节。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 01 剂型与规格简述 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 💊 剂型与规格要弄清\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>卡铂\u003C/strong>：注射用，常见规格50mg、150mg冻干粉。\u003C/li>\n        \u003Cli>\u003Cstrong>白蛋白紫杉醇\u003C/strong>：注射用，规格主要有100mg、150mg和200mg小瓶；与传统紫杉醇不同，无需溶剂稀释。\u003C/li>\n        \u003Cli>\u003Cstrong>信迪利单抗\u003C/strong>：注射用，规格常为100mg/瓶。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-block\">正确做法：每种药的实际用量由体表面积、肾功能等综合决定。每次用药只能在有资质的医院注射，绝不可自行操作。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 02 药物作用机制区别 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 🔬 作用机制各有千秋\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Col>\n        \u003Cli>\u003Cstrong>卡铂\u003C/strong>：属于铂类药，通过破坏细胞DNA抑制细胞分裂。\u003C/li>\n        \u003Cli>\u003Cstrong>白蛋白紫杉醇\u003C/strong>：属于抗微管药，阻断细胞分裂所需“支架”的形成，促使异常细胞凋亡。\u003C/li>\n        \u003Cli>\u003Cstrong>信迪利单抗\u003C/strong>：为免疫检查点抑制剂，激活自身免疫细胞，增强体内对异常细胞的清除能力。\u003C/li>\n      \u003C/ol>\n      \u003Cdiv class=\"drug-guide-tips-small\">✨ 这三类药协同后，提高整体治疗效果，有临床优势\u003Csup>[1]\u003C/sup>。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 03 用药时间和流程安排 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 ⏰ 给药顺序和用药流程\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cp>三药联合时通常同在住院或门诊日，由专业护士静脉给药。常规顺序为：\u003C/p>\n      \u003Col>\n        \u003Cli>先给白蛋白紫杉醇（点滴1小时以上）；\u003C/li>\n        \u003Cli>随后滴注卡铂（30-60分钟）;\u003C/li>\n        \u003Cli>最后为信迪利单抗，通常30-60分钟静注。\u003C/li>\n      \u003C/ol>\n      \u003Cdiv class=\"drug-guide-tips-block\">需要注意：每次注射至少间隔2-3周，具体以医生安排为准。化疗和免疫药联合过程中应密切观察反应。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 04 服用和输注注意事项 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 🧴 输注过程与注意要点\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>三药均必须静脉滴注，不能肌内或皮下注射。\u003C/li>\n        \u003Cli>开始输注前需评估过敏史和肾功能情况。\u003C/li>\n        \u003Cli>化疗当天建议饮食清淡，避免油腻生冷食物，输液过程保持安静休息。\u003C/li>\n        \u003Cli>部分人输注期间可能出现局部不适、过敏等反应，如果身体有明显不适需立刻告知医护。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-small\">正确做法：过程中医生视情况准备急救药品，应对意外反应。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 05 用药剂量及特殊调整 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 ⚖️ 用药剂量及调整规则\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>卡铂\u003C/strong>：剂量常以AUC（药物暴露面积法）或体表面积计算，常见AUC 5~6。\u003C/li>\n        \u003Cli>肾功能减退者（如老年患者、单肾、肾损伤）需适当减量，过度用药可导致肾损害。\u003C/li>\n        \u003Cli>\u003Cstrong>白蛋白紫杉醇\u003C/strong>：推荐剂量每次按体表面积计算（如260mg/m²，具体以医生处方为准）。肝功能障碍时需慎用或减量。\u003C/li>\n        \u003Cli>\u003Cstrong>信迪利单抗\u003C/strong>：通常200mg每2或3周一次，目前尚未见体重、肝肾功能影响较大调整需求，但极端体重、重度器官功能异常需谨慎。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-block\">特别提醒：用药调整须由医生定期评估，切勿凭自感擅自增减剂量。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 06 药物相互作用及联合禁忌 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 ⚠️ 联合用药的相互作用\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>这三种药联合时，会增强整体作用效果，但同时副作用风险也会提升。避免同时服用其他抑制骨髓或肝肾功能的药物，否则不良反应风险上升。\u003C/li>\n        \u003Cli>白蛋白紫杉醇有可能与某些药物（如酮康唑、红霉素等CYP3A4抑制剂）相互作用，需提前告知医生最近有无服用相似药物。\u003C/li>\n        \u003Cli>卡铂与阿米卡星、万古霉素等药物合用时有增加肾毒性风险，禁忌随意联用。\u003C/li>\n        \u003Cli>使用信迪利单抗时，避免同时接受高强度免疫抑制剂（如糖皮质激素、环孢素等）。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-block\">正确做法：用药期间主动告知医生所有在用药品，包括保健品和中草药。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 07 常见不良反应及处理方法 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 🚨 不良反应和危险信号\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>卡铂\u003C/strong>：常见副作用为骨髓抑制（白细胞/血小板减少）、肾功能损害、恶心呕吐、耳鸣。出现严重异常需及时处理。\u003C/li>\n        \u003Cli>\u003Cstrong>白蛋白紫杉醇\u003C/strong>：主要副作用为神经毒性（手脚麻木）、白细胞减少、脱发。小部分人易过敏。\u003C/li>\n        \u003Cli>\u003Cstrong>信迪利单抗\u003C/strong>：可能诱发免疫相关不良反应，包括皮疹、乏力、肝酶升高等，还可能有内分泌及其他器官毒性。极罕见出现重症反应。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-block\">特别提醒：一旦出现持久高热、皮疹严重、呼吸困难等异常，须第一时间就医。大部分副作用可通过调整药物或支持治疗恢复。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 08 储存方法和有效期管理 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 🗃️ 储存要求与过期处理\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>卡铂、白蛋白紫杉醇和信迪利单抗均为冷藏保存（2~8°C），避免冷冻，不可阳光直射。\u003C/li>\n        \u003Cli>药品开启后未用完部分建议及时废弃，不建议留作后用。\u003C/li>\n        \u003Cli>药品过期、外观异常（如混浊、胶团析出、变色）不得继续使用。\u003C/li>\n        \u003Cli>家庭未使用完的化疗药，建议送回医疗机构按危险废弃物处理。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-small\">正确操作：药品如转运途中超温，必须重新评估安全后决定使用。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 09 特殊人群用药调整要点 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 👵 老年人与特殊体质者的用药技巧\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>65岁以上或伴肾功能下降的患者，卡铂和白蛋白紫杉醇剂量需下调，防止副作用加重。\u003C/li>\n        \u003Cli>体质虚弱或伴其他疾病时，医院常规要求全程由家属陪护，并有医疗团队监控。\u003C/li>\n        \u003Cli>孕妇、哺乳期及儿童禁用三药，极特殊情况下需多学科会诊决定是否使用。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-block\">案例参考：一位75岁男性患者，因肾功能变差由顺铂改为卡铂联合白蛋白紫杉醇、信迪利单抗，避免了顺铂相关肾毒性，治疗过程更加安全。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 10 联合使用时的日常监测项目 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 👀 如何科学监测用药过程\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>建议每次用药前后严格检测血常规、肝肾功能、电解质。\u003C/li>\n        \u003Cli>定期监测体重变化、皮肤和神经状态。\u003C/li>\n        \u003Cli>联合方案期间须随访有无过敏、皮疹、持续发热、腹泻等表现。\u003C/li>\n        \u003Cli>长期方案需注意观察食欲、体力和生活自理能力。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-small\">数据表明：联合用药方案主要不良反应发生率45~67%[2]，积极监测有助于早期纠正。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 11 联合方案的操作经验总结 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 🌟 联合用药真实经验分享\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cul>\n        \u003Cli>有患者在化疗初期因顺铂相关副作用（肾指标升高）被及时调整为卡铂，后续未再发生严重反应。\u003C/li>\n        \u003Cli>临床上多个案例显示，白蛋白紫杉醇较传统紫杉醇副反应明显降低（如溶剂相关过敏），病人耐受性好。\u003C/li>\n        \u003Cli>信迪利单抗在首次用药期间需要严密观察，后期如无异常可以按标准周期执行。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tips-block\">正确做法：每次用药前主动告知医生近期身体变化，尤其是新出现的不适症状，配合随访计划。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 总结与用药核心提示 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">12 📝 结语及重点回顾\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Cp>卡铂、白蛋白紫杉醇、信迪利单抗三联用药方案，科学规范使用有助于提升治疗效果，降低不良反应风险。输注流程、剂量调整、药物相互作用、不良反应识别、储存方式、特殊人群注意点等每一项都不能马虎。\u003Cspan style=\"color:#378c6e;\">记住：\u003C/span>细节决定用药安全，药品使用一定遵循专业医师指导。如果遇到身体突变，请及时前往医疗机构处理。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-subtitle drug-guide-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔎 参考文献\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content-bg\">\n      \u003Col class=\"drug-guide-ref-list\">\n        \u003Cli>Yang, Y., et al. (2020). \"A Randomized Phase III Study of Camrelizumab in Combination With Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma.\" \u003Ci>Journal of Clinical Oncology\u003C/i>, 38(27), 3132-3141.\u003C/li>\n        \u003Cli>Kato, K., et al. (2019). \"Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced esophageal cancer: The KEYNOTE-590 study.\" \u003Ci>Journal of Clinical Oncology\u003C/i>, 39(15_suppl), 4000-4007.\u003C/li>\n        \u003Cli>National Comprehensive Cancer Network (NCCN). (2023). \"NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers.\"\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立、嵌入友好、淡雅风格全局样式 */\n.drug-guide-container {\n  max-width: 860px;\n  margin: 36px auto;\n  background: #f7fafc;\n  font-family: \"Microsoft YaHei\", Arial, Helvetica, sans-serif;\n  color: #2a3a3a;\n  padding: 40px 28px 40px 28px;\n  box-shadow: 0 8px 28px 0 rgba(68, 68, 68, 0.07), 0 1.5px 4px 0 rgba(44, 44, 44, 0.04);\n  border-radius: 24px;\n  box-sizing: border-box;\n}\n.drug-guide-title {\n  font-size: 2.4em;\n  font-weight: bold;\n  color: #264653;\n  margin-top: 0;\n  margin-bottom: 40px;\n  padding-bottom: 8px;\n  border-bottom: 2px solid #dde4ea;\n  text-shadow: 0 2px 10px rgba(180,200,220,0.12);\n  text-align: center;\n  letter-spacing: 1px;\n}\n.drug-guide-section {\n  margin-bottom: 32px;\n}\n.drug-guide-subtitle {\n  margin: 0 0 18px 0;\n  font-size: 1.35em;\n  font-weight: 700;\n  color: #20615b;\n  letter-spacing: 0.5px;\n  padding: 16px 22px 16px 16px;\n  border-radius: 14px 14px 0 0;\n  background: linear-gradient(90deg, #e1f3ef 45%, #edeff7 100%);\n  box-shadow: 0 1.5px 6px 0 rgba(77,171,154,0.08);\n  display: inline-block;\n  width: auto;\n  position: relative;\n}\n.drug-guide-bg {\n  background: linear-gradient(90deg, #e3f5ee 55%, #eeeeff 100%);\n}\n.drug-guide-content-bg {\n  background: #f9fbfd;\n  border-radius: 0 0 14px 14px;\n  margin-top: 0;\n  padding: 18px 26px 18px 20px;\n  border-left: 6px solid #b4cec2;\n  border-right: 6px solid #edefef;\n  box-shadow: 0 1px 7px 0 rgba(120,185,180,0.07);\n  font-size: 1.1em;\n  min-height: 80px;\n}\n.drug-guide-intro-bg {\n  background: linear-gradient(90deg, #f5fcfc 60%, #faf4ee 100%);\n  border-radius: 10px;\n  margin: 0 0 12px 0;\n  padding: 17px 24px 17px 18px;\n  border-left: 4px solid #96c6c2;\n  font-size: 1.17em;\n  color: #404850;\n}\n.drug-guide-tips-block {\n  background: #e7f3f0;\n  color: #22705c;\n  padding: 12px 18px;\n  border-radius: 8px;\n  margin-top: 18px;\n  margin-bottom: 8px;\n  border-left: 5px solid #67ae92;\n  font-weight: 500;\n  font-size: 1em;\n  box-shadow: 0 1px 7px 0 rgba(184,211,201,0.06);\n}\n.drug-guide-tips-small {\n  background: #f4fde8;\n  padding: 10px 15px;\n  font-size: 0.96em;\n  color: #40724d;\n  border-left: 4px solid #93c97f;\n  margin-top: 12px;\n  margin-bottom: 4px;\n  border-radius: 6px;\n}\n.drug-guide-ref-list {\n  margin: 13px 0 0 24px;\n  font-size: 1em;\n  line-height: 1.82;\n  padding-left: 0;\n  color: #547582;\n}\n.drug-guide-content-bg ul,\n.drug-guide-content-bg ol {\n  margin: 0 0 12px 22px;\n  padding: 0 0 0 6px;\n  line-height: 1.85;\n}\n.drug-guide-content-bg li {\n  margin-bottom: 5px;\n}\n@media (max-width: 600px) {\n  .drug-guide-container {\n    padding: 24px 6px 30px 6px;\n    border-radius: 0;\n  }\n  .drug-guide-title {\n    font-size: 1.19em;\n    padding-bottom: 2px;\n  }\n  .drug-guide-section {\n    margin-bottom: 25px;\n  }\n  .drug-guide-subtitle {\n    font-size: 1.07em;\n    padding: 10px 12px 9px 8px;\n    border-radius: 7px 7px 0 0;\n  }\n  .drug-guide-content-bg {\n    padding: 11px 8px 10px 7px;\n    min-height: 54px;\n    border-radius: 0 0 7px 7px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: ",507,"2025-07-14 15:27:28","食管鳞癌, 卡铂, 白蛋白紫杉醇, 信迪利单抗, 化疗, 免疫治疗, 用药细节, 不良反应","了解卡铂、白蛋白紫杉醇与信迪利单抗组合使用的详细治疗方案，优化疗效、降低副作用，助力食管鳞癌患者的康复之路。","2025-07-21 10:58:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]